StonvexLoading…
StonvexStonvexStonvexCore line items from TISI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $896.48M | $852.27M | $862.62M | $840.21M |
Operating Income | $14.07M | $10.14M | $-13.28M | $-39.80M |
Net Income | $-49.21M | $-38.27M | $-75.72M | $70.08M |
EPS (Diluted) | $-11.70 | $-8.64 | $-17.32 | $16.73 |
Total Assets | $485.45M | $528.37M | $565.74M | $616.64M |
Total Liabilities | $457.98M | $526.63M | $520.15M | $498.88M |
Cash & Equivalents | $18.14M | $35.55M | $35.43M | $58.08M |
Free Cash Flow OCF − CapEx | $-20.64M | $13.30M | $-21.42M | $-82.63M |
Shares Outstanding | 4.53M | 4.49M | 4.42M | 4.34M |